Literature DB >> 4977486

New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

M W Fisher, H B Devlin, F J Gnabasik.   

Abstract

The development of an antigen schema for Pseudomonas aeruginosa based on challenge protection in mice as distinguished from serological tests in vitro was described. For 342 cultures, seven groups of cross-protective homogeneity were defined.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4977486      PMCID： PMC284896          DOI： 10.1128/jb.98.2.835-836.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  7 in total

1.  A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa.

Authors:  E VERDER; J EVANS
Journal:  J Infect Dis       Date:  1961 Sep-Oct       Impact factor: 5.226

2.  [Not Available].

Authors:  W KOHLER
Journal:  Z Immun exp ther       Date:  1957-08

3.  [Research on O-antigens of Pseudomonas aeruginosa].

Authors:  I HABS
Journal:  Z Hyg Infektionskr       Date:  1957

4.  Observations on the antigenic structure of Pseudomonas aeruginosa.

Authors:  M VAN DEN ENDE
Journal:  J Hyg (Lond)       Date:  1952-09

5.  Serological and pyocine types of Pseudomonas aeruginosa from various sources.

Authors:  H Matsumoto; T Tazaki; T Kato
Journal:  Jpn J Microbiol       Date:  1968-03

6.  Protection by vaccination against Pseudomonas infection after thermal injury.

Authors:  K Markley; E Smallman
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490
  7 in total
  89 in total

1.  Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.

Authors:  S D Davis
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

2.  Cross-reactions of lipopolysaccharides of Pseudomonas aeruginosa in antipneumococcal and other antisera.

Authors:  M Heidelberger; D Horton; T H Haskell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.

Authors:  J E Pennington; G J Small; M E Lostrom; G B Pier
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

4.  Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.

Authors:  G C Tsay; M S Collins
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice.

Authors:  M Pollack; G B Pier; R K Prescott
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Specificity of early protective responses induced by pseudomonas vaccines.

Authors:  R J Jones
Journal:  J Hyg (Lond)       Date:  1972-06

7.  Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Authors:  C L Pierson; A G Johnson; I Feller
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors.

Authors:  R J Weinstein; L S Young
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs.

Authors:  S D Davis; J W Chandler
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

10.  Immunization of mice and chinchillas against Pseudomonas aeruginosa.

Authors:  P I Lusis; M A Soltys
Journal:  Can J Comp Med       Date:  1971-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.